arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

LEMAITRE VASCULAR INC

LMAT
$83.56 ▼ -4.33 (-4.93%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
83
Health
Excellent
Bullish
auto_awesome

Analytical Summary

LEMAITRE VASCULAR INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.9B
Dividend Yield 0.30%
Revenue Growth 9.6% ↘
Op. Margin 29.0% ↗
ROIC 3.7% ↗
FCF / Share $0.70 ↗
Trailing P/E 111.4x
Price / Book 4.6x
FCF Yield 0.8%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$70.38M
↑ +9.6% —
Net Income Profit after all expenses
$15.68M
↑ +42.4% —
Operating Margin Operating profit as % of sales
29.0%
↑ +8.5% 84th
FCF / Share Free cash flow per share
$0.70
↑ +5.5% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
87
Returns ↑
80
Financial Health ↓
85
Cash Quality ↑
78

Dividend History

Dividend / share · sourced from SEC filings
$0.80 Latest / share
+25.0% YoY
+17.2% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters